扩大大小的DNA基的光:报告DNA序列和结构与非自然的遗传集
Andrew T Krueger1, Eric T Kool
1Department of Chemistry, Stanford University, Stanford, California 94305, USA.
Journal of the American Chemical Society
|March 4, 2008
概括
扩展DNA (xDNA) 基体表现出独特的光特性. 与互补DNA基的杂交显著改变了xDNA光,这表明在生物物理分析和生物技术中的应用.
科学领域:
- 生物化学和分子生物学
- 合成生物学 合成生物学
- 频谱学是一种光谱学.
背景情况:
- 扩展DNA (xDNA) 是一种合成遗传系统,其基因对比自然DNA大.
- 之前的工作确立了xDNA的合成和螺旋组装特性.
- 作为研究工具和模仿自然DNA功能的xDNA的潜力正在调查中.
研究的目的:
- 为了研究xDNA (xA,xC,xG,xT) 中四个扩展基的光特性.
- 评估xDNA光辐射如何受到寡合体长度,组成和杂交的影响.
- 探索XDNA光在生物物理分析和生物技术中的潜在应用.
主要方法:
- 合成与DNA寡核酸合的xDNA核酸的短小分子.
- 对xDNA单体和小分子的光谱分析,包括吸收和发射光谱.
- 用对应的DNA基相对应的XDNA基进行杂交实验,以观察光变化.
主要成果:
- xDNA基在260nm和330nm附近吸收光,在紫色-蓝色范围内 (380-410nm) 有效发射,量子产量为0.30-0.52.
- 短的XDNA同类寡合体显示出中度的自我灭,除了xC,它表现出长度增强的光;xA多元体显示出更长的波长发射 (520nm).
- 与 xDNA 序列相反的互补DNA 基的杂交诱导了显著的光变化,包括波长转移,增强 (例如,xG 与腺素) 和灭 (例如,xT/xC 与关氨酸).
结论:
- xDNA基的光特性是不同的,并且对它们的序列上下文和杂交状态敏感.
- xDNA基和互补DNA基之间的特定相互作用导致可预测的光调节.
- 这些发现凸显了xDNA基作为生物物理研究和生物技术工具的光探针的潜在用途.
相关概念视频
Pulse rhythm
Pulse rhythm refers to the pattern of pulsations within specific intervals, offering valuable insights into the regularity or irregularity of the heart's beats as observed through the pattern of pulsation within specific intervals. A regular pulse exhibits a consistent heart rate with uniform waveforms and pulsation force, variations of which can be classified as normal, weak, or bounding.
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac muscle...
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac muscle...
Disturbances in Heart Rhythm
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Holter Monitor: 24-Hour Monitoring
Holter monitoring is a continuous electrocardiography (ECG) recording that tracks the heart's electrical activity over an extended period, generally 24 to 48 hours. This noninvasive diagnostic tool detects irregular heart rhythms that may not be captured during a standard ECG performed in a clinical setting.DeviceThe Holter monitor is a portable, small device connected to several electrodes on the patient's chest. These electrodes detect the heart's electrical signals and transmit them to the...
Dysrhythmias IV: Characteristics of Bradyarrhythmias
Bradyarrhythmias are cardiac rhythm disorders characterized by a slower-than-normal heart rate, typically defined as fewer than 60 beats per minute. Some of which are discussed here:Sinus BradycardiaSinus bradycardia presents a heart rate lower than 60 beats per minute, with a regular rhythm originating from the SA node. The ECG typically shows normal P waves preceding each QRS complex, a normal PR interval (0.12 to 0.20 seconds), and a normal QRS duration (0.06 to 0.10 seconds).First-Degree AV...
Dysrhythmias V: Evaluating Dysrhythmias
Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...
Dysrhythmias VI: Management of Dysrhythmias
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...


